Life Healthcare Group Holdings Limited (LTGHY)
OTCMKTS · Delayed Price · Currency is USD
2.470
-0.110 (-4.26%)
Dec 12, 2025, 3:53 PM EST
LTGHY Revenue
In the fiscal year ending September 30, 2025, Life Healthcare Group Holdings had annual revenue of 25.40B ZAR with 6.06% growth. Life Healthcare Group Holdings had revenue of 13.12B in the half year ending September 30, 2025, with 10.20% growth.
Revenue
25.40B ZAR
Revenue Growth
+6.06%
P/S Ratio
0.64
Revenue / Employee
1.24M ZAR
Employees
20,436
Market Cap
942.16M USD
Revenue Chart
* This company reports financials in ZAR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 25.40B | 1.45B | 6.06% |
| Sep 30, 2024 | 23.95B | 1.06B | 4.61% |
| Sep 30, 2023 | 22.89B | 2.14B | 10.31% |
| Sep 30, 2022 | 20.75B | -6.31B | -23.32% |
| Sep 30, 2021 | 27.06B | 3.06B | 12.73% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Life Healthcare Group Holdings News
- 15 days ago - Life Healthcare Group Holdings Limited (LTGHY) Q4 2025 Earnings Call Transcript - Seeking Alpha